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Carbonic anhydrase (CA) catalyzes the reversible hydration of
CO2. CA is expressed in most segments of the kidney. CAII
and CAIV predominate in human and rabbit kidneys; in
rodent kidneys, CAXII, and CAXIV are also present. CAIX
is expressed by renal cell carcinoma (RCC). Most of these
isoforms, except for rodent CAIV, have high turnover
rates. CAII is a cytoplasmic enzyme, whereas the others
are membrane-associated; CAIV is anchored by
glycosylphosphatidylinositol linkage. Membrane polarity
is apical for CAXIV, basolateral for CAXII, and apical and
basolateral for CAIV. Luminal membrane CAs facilitate the
dehydration of carbonic acid (H2CO3) that is formed when
secreted protons combine with filtered bicarbonate.
Basolateral CA enhances the efflux of bicarbonate via
dehydration of H2CO3. CAII and CAIV can associate with
bicarbonate transporters (e.g., AE1, kNBC1, NBC3, and
SCL26A6), and proton antiporter, NHE1 in a membrane
protein complex called a transport metabolon. CAXII and
CAXIV may also be associated with transporters in normal
kidney and CAIX in RCCs. The multiplicity of CAs implicates
their importance in acid–base and other solute transport
along the nephron. For example, CAII on the cytoplasmic face
and CAIV on the extracellular surface provide the ‘push’ and
‘pull’ for bicarbonate transport by supplying and dissipating
substrate respectively.
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Carbonic anhydrase (CA) is a zinc metalloenzyme that
catalyzes the reversible hydration of CO2 according to the
reaction:
HþþHCO3 $ H2CO3  !CA CO2 þH2O ð1Þ
CO2 gas dissolves in water and is in equilibrium with the acid
H2CO3. The Henderson–Hasselbalch equation relates pH,
HCO3
 concentration, and partial pressure of CO2 gas in
physiologic solutions:
pH ¼ 6:1þ log ð½HCO3 
=½0:03  pCO2
Þ ð2Þ
The uncatalyzed hydration of CO2 is relatively slow, whereas
the turnover number for CAII is of the order of 106 s1.1,2
At present there are 15 known isoforms of CA, which
differ in kinetic properties, susceptibility to inhibitors, and
specific tissue distribution. From the reactions 1 and 2
above, it is logical to assume that CA can facilitate renal
acidification, because the concentrations of CO2 and HCO3

are interdependent. In addition, CA can modulate acid–base
transport in three other ways. First, CA can make dissolved
HCO3
 available for rapid conversion to CO2, thereby
increasing the amount of transported CO2 by the amount
of HCO3
 present in solution. Second, CA can mobilize
HCO3
 diffusion for CO2 transport, in a process known as
facilitated diffusion, whereby there is HCO3
 diffusion and
simultaneous Hþ transport in the presence of a mobile
buffer, such as phosphate or albumin.3,4 For example, at pH
7.4 there are 20 times more HCO3
 ions as CO2 molecules, so
that CO2 diffusion may be increased by 20-fold.
4,5 Third,
Enns5 showed that CA alone, in the absence of HCO3
 ions,
(pH 5.2), directly enhances transport, perhaps by acting as a
carrier for CO2.
CAII accounts for 495% of CA activity in the kidney and
resides in the cytosol. In non-rodent species (e.g. human,
rabbit, and bovine) most of the remainingB5% of renal CA
is membrane-associated and comprised of CAIV and
CAXII.6–8 In addition to CAIV and CAXII, CAXIV, and
CAXV are expressed in the kidney of rodent species.9–12
Although CAIX is not expressed in normal kidney, it is
commonly found in neoplasms arising from renal tissue,
particularly renal clear-cell carcinoma.13
In the following sections we will examine the function of
CA isoforms in acid/base physiology of the kidney by
defining the following parameters for each of the renal CA
isoforms: (1) expression along the nephron segments (cell
types), (2) subcellular localization, and (3) functional
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associations with acid/base transporters. Studies within the
last 10 years have demonstrated that CAs associate with acid/
base transporters to form Hþ /HCO3
 transport metabo-
lons.14 Association of CAs with transporters has been shown
to markedly enhance Hþ /HCO3
 transport, and thus via
mass action CAs provide the ‘push’ and ‘pull’ for Hþ /HCO3

transport by accumulating or dissipating substrate.
CA ISOFORMS
To date 15 CA isoforms have been identified of which twelve
are catalytically active; CAs VIII, X, and XI are CA-related
proteins that are not catalytically active owing to the absence
of one or more of the conserved histidine residues that are
required for coordination of Zn, which is essential for CA
enzyme catalysis.11,15 CAs can be divided into three groups
based on their domain structure that is comprised of a CA
catalytic domain along with other structural features that
influence cellular localization (Figure 1). The cytosolic CA
isoforms for which CAII serves as a prototype, also include
CAs I, III, and VII, which are comprised of a CA domain
encompassing the enzyme active site and the three conserved
histidine residues found in all catalytically active CA
isoforms.
The CAV isoforms are expressed in mitochondria owing to
the inclusion of a 33 amino-acid classical mitochondrial
leader sequence in the 317 amino-acid precursor peptide
containing a CA domain. The CAV isoform includes two
homologs, CAVA and CAVB that differ in their tissue
distributions: CAVB is expressed in most tissues, whereas
CAVA expression is restricted to liver, skeletal muscle, and
kidney.16 Addition of a signal sequence to a CA domain and a
C-terminal extension that is rich in hydrophilic amino acid
produces CAVI, the lone secreted isoform which is expressed
in the salivary gland of a number of mammalian species.17,18
There are now five membrane-associated CA isoforms
with the recent addition of CAXV to this group,12 three of
which (CAs IX, XII, and XIV) are expressed as single-pass
transmembrane proteins.9,19–21 In addition to a conserved
catalytic domain found in all CA isoforms, CAIX contains an
N-terminal proteoglycan-like domain that may function in
cell adhesion.22 CAIV and the closely related CAXV,12 are
tethered to the outer leaflet of the plasma membrane via a
glycosylphosphatidylinositol lipid anchor (GPI anchor) that
typically results in the luminal or apical surface expression of
the protein in polarized epithelial cells.23–25 However, recent
studies in our laboratory have revealed an exception to this
rule for CAIV expression in proximal tubule epithelial cells, as
is discussed in detail below.
ENZYMATIC ACTIVITY
The a class of CAs comprises zinc-containing metallo-
enzymes that catalyze the reversible hydration of CO2
according to the reaction (3):
CO2þH2O !CA H2CO3 $ Hþ þHCO3 ð3Þ
CO2 hydration occurs in two distinct steps
26 as shown below.
E Zn OH þ CO2 $ E ZnHCO3 þH2O
$ E Zn OH2 þHCO3 ð4Þ
First a nucleophilic attack by the zinc-bound hydroxide
occurs at the carbonyl carbon of CO2 to form zinc-bound
bicarbonate. For the prototype CAII enzyme the second-
order rate constant for CO2 hydration (Kcat/Km) approaches
the diffusion control limit. The second step regenerates the
active zinc hydroxide species, when a proton is transferred
from zinc-bound water to a solvent buffer molecule in two
stages via the His64.
Hisð64ÞE Zn OH2 $ HþHisð64ÞE ZnOH
þ B
$ Hisð64ÞE Zn OH
þ BHþ
ð5Þ
In stage 1 there is an intra-molecular transfer of a proton
from zinc-bound water to a protein side chain with a pKa of
7, then an inter-molecular transfer of the proton to solvent
buffer molecule. In reaction (4) E denotes a CA enzyme and
B indicates the solvent buffer molecule (5). Histidine residue
64 of the CAII molecule functions as a proton shuttle in the
rate-limited step for CO2 hydration at high substrate and
buffer concentrations. Replacement of His-64 with non-
ionizable amino acids such as alanine or glutamine markedly
reduces hydratase activity.27,28 Catalytic rates exhibited by
CAII are among the highest measured (106 s1)26 (Figure 2).
Reduced activity of some CA isoforms (CAIII), as well as
species differences in CA isoform activity, provides additional
insights into the function of other amino-acid residues
within the CA catalytic domain. The cytosolic CAIII isoform
that is abundantly expressed in skeletal muscle and adipose
tissue and to a lesser extent in brain and liver, exhibits the
lowest hydratase activity of the CA isoforms (see Figure 2).
Although CAII and CAIII have similar backbone conforma-
tions (see Figure 1), CAIII is less efficient at proton shuttling
due in part to replacement of His with lysine at residue 64.29
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Figure 1 | CA isoforms. CAs are grouped according to their
subcellular localization (i.e. cytosolic, mitochondrial, secreted,
single-pass transmembrane, and GPI-anchored proteins); the
domain structures are shown at the right of each isoform.
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In addition, residue 198 of CAIII contains a phenylalanine
phenyl ring about 5 Angstrom from Zn whereas a leucine is
present in CAII, perhaps resulting in steric constriction of the
CAIII active site. Consistent with this supposition, replace-
ment of Phe with leucine at position 198 increases the rate of
CAIII catalysis by at least 10-fold.30
The amino-acid residues adjacent to His-64 also influence
CAII activity.31 Introduction of bulky amino acids at position
65 decreases CAII Kcat up to 26-fold by disrupting the active
site solvent network that facilitates proton transfer. In rodent
CAIV (mouse, rat) a glutamine resides at position 63, and as
a result the rodent enzyme has 10–20% of the activity of
CAIV orthologs with a glycine at position 63 (rabbit, bovine,
and human).32 The presence of a bulkier side chain at
position 63 may alter the conformation of His64 and thereby
decrease the efficiency of the proton shuttling reaction. The
importance of CAIV in renal physiology is underscored by
the fact that the 80% decrease in CAIV activity in rodents
owing to the glutamine residue at position 63 is associated
with the compensatory expression of additional CA isoforms
in rodent kidney (e.g. CAXIV and CAXV; see below).
The active site of CAII also contains a hydrophobic
pocket, which includes valine at residues 121 and 143.33
Substitution of Val143 with amino acids containing large side
chains dramatically reduces hydratase activity. For example, a
Val143-Iso substitution reduces activity eightfold whereas
Val143-Tyr virtually destroys enzyme activity by reducing
Kcat/Km for CO2 hydrations 3000–10
5-fold.33 Blockade of the
hydrophobic pocket with large amino-acid side chains may
hinder the ability of CO2 to approach the zinc-hydroxide
moiety with correct orientation to react. Overexpression of
the CAII V143Y mutant displaces endogenous wild-type CAII
from putative CAII binding sites and thereby functions as a
dominant-negative mutant that may be used to assess the
function of CAII interactions in facilitation of ion transport
(see below).
CAII
CAII is expressed as a 29 kDa monomeric protein (259 amino
acids) in the cytosol of a wide variety of tissues (e.g. bone,
brain, eye, stomach, intestine, liver, pancreas, kidney, red
blood cells, salivary glands, and uterus),34–36 and is
characterized by its high enzymatic activity and inhibition
by exposure to sodium dodecyl sulfate (SDS), owing to the
absence of stabilizing disulfide bridges.7,8,37 As noted above,
CAII expression in the nephron accounts for 95% of total CA
activity in the kidney, and studies describing the localization
of CAII messenger RNA (mRNA) and protein expression in
specific nephron segments was recently reviewed in detail.38
In summary and generalizing from a variety of animals, CAII
is expressed in proximal tubule, thin descending limb, thick
ascending limb, and intercalated cells of the cortical
collecting duct (CCD), outer medullary collecting duct
(OMCD), and inner medullary collecting duct (Figure 3).
The function of CAII in renal Hþ /HCO3
 transport is
perhaps best understood by examining CAII interactions
with specific transporters.
Anion exchangers
CAII binding to the carboxyl terminus of human AE1 (band
3) was the first report of direct interaction between CAs and
members of the bicarbonate transporter (BT) family.39
Evidence for CAII interaction with AE1 included: (1) CAII
binding to a glutathione S transferase (GST)-AE1 C-terminal
peptide fusion in vitro; (2) blockade of AE1/CAII binding by
an antibody to the C-terminal region of AE1; (3) lectin-
induced co-clustering of AE1 and CAII; and (4) co-
precipitation of CAII with AE1.39 CAII has since been shown
to interact with additional members of the SLC4A family of
BTs including three of the anion exchangers (AE1-3).39,40
Association of CAII with anion exchangers facilitates
bicarbonate transport as demonstrated by the acetazola-
mide-mediated reduction of chloride/bicarbonate exchange
activity in human embryonic kidney (HEK)293 cells
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Figure 2 | Catalytic activities of select CA isoforms. Upper panel:
CAs II and III represent the range of hydratase activity from highest to
lowest, respectively. CAs expressed in normal kidney include cytosolic
CAII, and membrane-associated CAIV and CAXII, which exhibit
exceptionally high catalytic activity. CAIX, which is expressed in RCCs,
has a catalytic rate comparable to CAIV. Lower panel: a comparison of
the specific activity of CAIV isoforms from mouse rodent species with
other species reveals that the hydratase activity of rabbit, bovine, and
human (not shown) CAIV is comparable to the activity of CAII,
whereas a Gly63-Gln substitution in rodent CAIV reduces catalytic
activity by several fold. The recently described CAXV isoform exhibits
low hydratase activity comparable to CAIII. References: aKhalifah,
J Biol Chem 1971; 246: 2561, Jackman, et al. Biochemistry 1996; 35:
16421, Steiner, et al. Eur J Biochem 1975; 59: 253, bJewell et al.
Biochemistry 1991; 30:1484, cBaird, et al. Biochemistry 1997; 36: 2669,
dWingo, et al. Biochem Biophys Res Commun 2001; 288: 666,
eUlmasov, et al. Proc Natl Acad Sci USA 2000; 97: 14212, fWhittington,
et al. J Biol Chem 2004; 279: 7223, gKarhumaa, et al. J Biol Chem 2000;
275: 16044, hTamai, et al. Proc Natl Acad Sci USA 1996; 93: 13647, and
iHilvo, et al. Biochem J 2005; 392: 83.
Kidney International (2007) 71, 103–115 105
JM Purkerson and GJ Schwartz: Carbonic anhydrases in the kidney r e v i e w
transfected with AE1 complementary DNA.41 In addition,
AE1 mutants, unable to bind CAII, exhibit reduced HCO3

transport. Finally, overexpression of a functionally inactive
CAII mutant (V143Y) inhibits chloride/bicarbonate exchange
by anion exchangers by displacing wild-type CAII from its
binding site on AE1.41 Similar results were obtained for AE2
and AE3.
CAII physically associates with anion exchangers (AE1-3)
via an acidic motif in the C-terminal region of the
transporter.39 Although the COOH tail of AE1 contains four
putative motifs, CAII binding is mediated only by the
D887ADD motif.42 Binding to AE2 requires the homologous
sequence, D887ANE.42 The corresponding interaction motif
located in CAII is comprised of a basic patch of amino acids
comprised of histidine and lysine in the N-terminal portion
of the enzyme.40
Most if not all BT family members contain a consensus
CAII binding motif consisting of a hydrophobic residue
followed by at least two acid residues within the next four
amino acids. CAII binding to members of the BT family is
pH dependent. In vitro binding studies have consistently
demonstrated that CAII binding to AE’s and NBC3 (see
below) is highest at pH 5 and binding affinity is markedly
reduced at pH values above 7.39 The pH dependence of CAII
binding most likely reflects increased protonation of basic
residues (lysine and histidine) within the transporter binding
site of CAII leading to increased electrostatic interactions
with acidic residues of the anion transporter. The influence of
pH on the interactions between CAII and BT raises the
possibility that the pH of the subplasmalemma microenvir-
onment may regulate the stoichiometry of CAII-transporter
association in a dynamic manner.
kNBC1
Sodium bicarbonate co-transporters include the kidney
isoform, kNBC1 (NBC1a), an electrogenic sodium BT that
is expressed on the basolateral membrane of proximal tubule
cells.43 The HCO3
: Naþ stoichiometry is shifted from 3:1 to
2:1 mode in response to phosphorylation of Ser982 by protein
kinase A, and the stoichiometry shift is accompanied by flux
reversal from efflux in the 3:1 mode to influx in the 2:1
mode.43 An acidic cluster of amino acids (D986 NDD), that is
homologous to the (D887ADD) CAII binding site in AE1, is
required for the phosphorylation-induced stoichiometry
shift. CAII binding to kNBC1 was first demonstrated
by isotherm calorimetry studies in which CAII bound
with high affinity (Kd¼ 160710 nM) to a single site on a
kNBC1 carboxy-terminus peptide (amino acids 915–1035:
kNBC19151035).44 In kNBC1 there are two clusters of acidic
amino acids, L958DDV and D986NDD, which are involved in
binding to CAII, and site-directed mutagenesis studies reveal
that the first aspartate residue in each cluster is critical for
CAII binding.45
Facilitation of kNBC1-mediated bicarbonate transport by
CAII was demonstrated in mouse proximal convoluted cell
line cell transfectants in which mutations of the two putative
CAII binding sites in kNBC1 exhibited a positive correlation
between CAII binding and flux inhibition by acetazol-
amide.45 Interestingly, acetazolamide reduced bicarbonate
flux only when the transporter was in efflux 3:1 mode;
acetazolamide inhibited kNBC1-mediated flux by 65% only
when the Ser982 was not phosphorylated by protein kinase A.
Although in vitro phosphorylation of a kNBC1 C-terminal
peptide containing Ser982 located between the two CAII
binding motifs increased CAII binding, point mutants in the
D986NDD motif of intact kNBC1 dissociated the CAII
binding from the loss of the protein kinase A-mediated
stoichiometry shift, suggesting that factors other than CAII
binding are involved in the transition from 3:1 to 2:1 mode.
NBC3
NBC3 is an electroneutral ethylisopropylamiloride-sensitive
and di-isothiocyanatostilbene 2,20-disulfonic acid disodium
salt hydrate-insensitive sodium bicarbonate co-transporter
that is expressed in heart, skeletal muscle, salivary glands, and
kidney.46,47 NBC3 is expressed apically by a-intercalated cells
in the kidney, where it may directly associate with vacuolar
Hþ -ATPase47 and contribute to cell pH regulation. On the
other hand, the role of NBC3 in mediating bicarbonate
absorption in the OMCD is minor (B15% of total).48
Evidence for CAII interaction with NBC3 comes from studies
by Casey and co-workers showing that in an in vitro binding
assay CAII binds to a GST fusion peptide containing the
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Figure 3 | Localization of CA isoforms along the nephron. CAII
(yellow stripe) is expressed within the cytoplasm of virtually all
nephron segments with the exception of the loop of Henle and the
thin ascending limb. CAIV (green stripe) is both apically and
basolaterally expressed in the S1 and S2 segments of the proximal
tubule and the thick ascending limb. In the distal nephron CAIV is
expressed exclusively on the luminal (apical) surface of a-intercalated
cells of the CCD and acid secreting cells of the medullary collecting
duct. CAXII (blue stripe) is found on the basolateral membrane of S1
and S2 segments of the proximal tubule and the thick ascending
limb. In the distal nephron CAXII is located in distal convoluted
tubules, principal cells of the CCD, and the medullary collecting duct
of some species. In rodent species CAXIV is expressed on the luminal
surface of cells in the S1 and S2 segments of the proximal tubule and
the thick ascending limb.
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NBC3 cytoplasmic tail.49 Also in HEK293 cells co-transfected
with CAII and NBC3, CAII is recruited to the plasma
membrane, whereas in cells transfected with CAII alone or
co-transfected with a NBC3 C-terminal deletion mutant,
CAII expression is distributed throughout the cytoplasm.49
The cytoplasmic tail of NBC3 contains two putative CAII
binding motifs LDDLM (CAB1) and LQDDDD (CAB2);
however only mutation of aspartic acid residues (D1135 and
D1136 in CAB1) reduced CAII binding, whereas mutagenesis
of aspartic acid residues within CAB2 was without effect.49
These findings indicate that only one site is required for
binding. Evidence for facilitation of NBC3-mediated trans-
port by CAII was provided by co-transfection studies in
HEK293 cells, in which the dominant-negative CAII (V143Y)
reduced NBC3-mediated recovery from an intracellular acid
load by B30%, presumably by competing with endogenous
CAII for binding to NBC3. Treatment of cells with cyclic
adenosine monophosphate agonists also inhibited NBC3
activity (40–50%). However unlike NBC1, protein kinase A
did not phosphorylate NBC3 in vitro, indicating that
phosphorylation by protein kinase A does not regulate CAII
binding to NBC3.
SLC26A6
This anion exchanger is expressed in the brush border
membrane of proximal tubule epithelial cells, where it may
mediate chloride/formate exchange, thereby contributing to
NaCl reabsorption.50 Although SLA26A6 transports a variety
of anions including sulfate, formate, oxalate, nitrate, and
iodide,51 the most physiological relevant transport in some
tissues may be Cl/HCO3
 or Cl/OH exchange.52–54 As the
SLC26A6 cytoplasmic tail contains consensus CAII binding
sites, Alvarez et al.53 utilized an affinity blotting assay to
investigate CAII binding to SLC26A6. GST fusion constructs
containing residues Q497 to D633 of the SLC26A6 cytoplasmic
tail were resolved by SDS-polyacrylamide gel electrophoresis,
transferred to polyvinylidene fluoride membrane, and then
incubated with HEK293 lysate expressing endogenous CAII.
CAII binding to GST-SLC26A6-Ct was detected by probing
with anti-CAII antibody. The CAII binding motif within the
SLC26A6 cytoplasmic tail was defined with an in vitro
binding assay where plate-immobilized CAII was incubated
with GST fusion peptides of the SLC26A6 cytoplasmic tail
containing five putative CAII binding sites. Only constructs
encompassing the 546DVDF549 motif bound CAII. In the
HEK293 cell transfection model acetazolamide and domi-
nant-negative CAII reduced Cl/HCO3
 exchange by
SLC26A6 B50 and 40%, respectively. Furthermore, a
SLC26A6 mutant lacking the CAII binding site exhibited a
B40–50% reduction in transport activity. Thus, CAII
interaction with SLC26A6 facilitates bicarbonate transport.
As the renin–angiotensin system regulates pancreatic
bicarbonate secretion via a protein kinase C (PKC)-
dependent mechanism,55 Alvarez et al.56 investigated the
effect of angiotensin receptor signaling and PKC activation
on SLC26A6 transport activity. AT1aR signaling inhibited
bicarbonate transport by SLC26A6, and this effect was
blocked by a PKC inhibitor. PKC activation by phorbol ester
(phorbol 12-myristate 13-acetate) inhibited transporter
activity, and induced dissociation of CAII from SLC26A6 as
determined by co-immunoprecipitation. A S553A substitution
within SLC26A6 abrogated inhibition of transporter activity
by phorbol 12-myristate 13-acetate and blocked the effect of
PKC activation on reduction of CAII/SLC26A6 association.
These studies indicate that PKC-mediated phosphorylation
of S553 disrupts CAII binding to SLC26A6, and represents
the first report of a kinase-dependent disruption of a CA-
transport metabolon.
NHE1
CAII also associates with NHE1, a ubiquitously expressed
glycoprotein that protects cells from intracellular acidifica-
tion by exchanging one intracellular proton for one extra-
cellular sodium.57 Association between CAII and NHE1 has
been demonstrated in vitro by affinity blotting and by solid
phase binding assays, where GST fusion proteins containing
the C-terminal tail of NHE1 bound to immobilized CAII.58
Interaction between NHE1 and CAII in situ was demon-
strated by co-immunoprecipitation from cells transfected
with NHE1 and CAII.58 CAII binding to NHE1 involves a
motif within the C-terminal tail that is distinct from the
consensus acidic cluster that comprises the CAII binding
motif found in BT family members.
The region of NHE1 that binds to CAII was localized to
a 13 amino-acid peptide (790RIQRCLSDPGPHPE803) using
a series of GST fusion peptides containing the C-terminal
tail of NHE1 in a variety of binding assays.59 Site-directed
mutagenesis within this 13 amino-acid sequence revealed that
the S796D797 residues (underlined above) were critical for
CAII binding to NHE1. Facilitation of sodium/hydrogen
exchange by CAII was demonstrated using AP-1 cells
transfected with NHE1, in which co-transfection with CAII
increased the rate of cell pH recovery from a bicarbonate-
dependent acid-load (in CO2/HCO3
 buffer), and this effect
was inhibited in the presence of the CA inhibitor acetazol-
amide.58 On the other hand, CAII co-transfection did not
increase pH recovery from acid-loaded cells expressing the
S796D797 mutation of NHE1.59 Finally, co-transfection with a
dominant-negative CAII mutant having a V143Y mutation
reduced recovery relative to transfection of NHE1 alone,
presumably owing to displacement of endogenous CAII from
its binding site on NHE1.58
Association of CAII with other NHE’s, such as NHE3 in
the proximal tubule, has not been reported; however, the
NHE3 C-terminal tail contains a putative CAII binding motif
(rabbit NHE3: 713ERELELSDPEEAP725)59 suggesting that a
CAII-NHE3 proton transport metabolon may exist in
proximal tubule cells of the kidney. Thus, CAs not only
facilitate bicarbonate transport by BT family members, but
they can also associate with at least one member of the NHE
family of cation transporters and facilitate proton efflux via
sodium/hydrogen exchange.
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In contrast to SLC26A6, CAII association with NHE1 is
positively regulated by phosphorylation. NHE1 activity is
regulated by growth factors and G-Protein Coupled Recep-
tors through activation of the Ras-extracellular signal-
regulated kinase (ERK) pathway and may involve direct
phosphorylation of NHE1 by the ERK pathway60,61 or
phosphorylation of NHE1 by kinases functioning upstream
of ERK; such as NIK, Nck-Interacting Kinase,62 or by a
downstream kinase, p90rsk.60 Phosphorylation of an NHE1
C-terminal peptide of 182 amino acids by heart cell extracts
or ERK, but not by Ca2þ /calmodulin-dependent protein
kinase II, increased CAII binding.59 The site of phosphoryla-
tion by ERK is probably non-overlapping with the CAII
binding site, because an S796A mutation did not affect
phosphorylation by ERK2, indicating that ERK2 phosphor-
ylates another residue.59 The S796A mutation also failed to
decrease CAII binding to the phosphorylated peptide,
suggesting that phosphorylation of another site in the
C-terminal tail of NHE1 induces a conformational shift in
NHE1 that favors CAII binding.59 Thus, mitogenic signal-
transduction stimulates NHE1 activity, at least in part,
through an ERK pathway-dependent increase in CAII
association with NHE1 to form a proton transporting
metabolon (Figure 4).
CAIV
CAIV is the most widely distributed of the membrane-
associated CA isoforms, with abundant expression observed
in several tissues including, kidney, heart, lung, gall bladder,
distal small intestine, colon, pancreas, capillary endothelium,
and skeletal muscle.24,63–70 CAIV is one of three membrane-
associated CA isoforms, the others being CAXII, and in
rodent species CAXIV, that account for the remaining B5%
CA activity in the kidney not contributed by CAII. Studies
characterizing CAIV expression in the nephron segments
were recently reviewed in detail.38 In summary, CAIV is
expressed in acidifying nephron segments in the proximal
tubule (S24S1bS3) and in distal nephron, including outer
and inner medullary collecting ducts and a-intercalated cells
of the cortical collecting duct (see Figure 3). A major role for
CAIV in urinary acidification has been demonstrated in
studies where inhibition of luminal CA activity eliminates
nearly all net bicarbonate reabsorption in the proximal
tubule,71 inner stripe of the outer medullary collecting duct,72
and in CAII-deficient patients and mice where inhibition of
CA activity diminishes renal acid secretion.73,74
CAIV is unique among CA isoforms, because it is tethered
to the plasma membrane via a GPI anchor.23,24 Human and
rabbit CAIV are synthesized as 312 and 308 amino-acid
precursors, respectively, that include an N-terminal signal
peptide, and a COOH-terminal domain containing a putative
transmembrane domain that is cleaved upon GPI-anchor
attachment in the endoplasmic reticulum.75,76 CAIV contains
two disulfide linkages that confer resistance to denaturation
by exposure to the detergent SDS (0.2–5%), which inactivates
most other CA isoforms. Thus SDS-resistance has enabled
determination of the CAIV contribution to total hydratase
activity in tissues containing multiple CA isoforms.24,77
Rabbit CAIV has a predicted molecular weight of 34 kDa,
however CAIV expressed in kidney cortex and medulla
exhibit apparent molecular weights of B46 and 47–60 kDa,
respectively, owing to glycosylation.69 This contrasts with
CAIV in human kidney tissue that migrates in SDS–poly-
acrylamide gel electrophoresis with an apparent molecular
weight close to the predicted mass of 35 kDa. Rabbit CAIV
contains two putative N-glycosylation sites, and treatment
of rabbit CAIV with N-glycanase reduces the apparent
molecular weight to B34 kDa, confirming the extensive
glycosylation of CAIV in rabbit kidney.69,76 Differences in the
glycosylation patterns of the expressed protein in the kidney
cortex and medulla may reflect cell-type specific post-
translational modification of CAIV in renal epithelia cells,
and might in part explain differences in apparent cellular
targeting in proximal versus distal nephron segments (see
below).
CAIVs from human, bovine, and rabbit tissues are high-
activity enzymes (see Figure 2), whereas CAIV from mouse
and rat have only 10–20% as much catalytic activity.32
Examination of the sequences revealed that human, bovine,
and rabbit CAIVs have a glycine residue at position 63,
whereas mouse and rat have a glutamine in this position.
Indeed, the low activity of mouse CAIV can be improved by
the Q63G substitution.32 The lower activity of the rodent
CAIVs is likely due to the Q63 substitution, which reduces the
efficiency of proton transfer by the adjacent histidine (H64).32
In previous studies of CAII this histidine was found to be an
efficient proton shuttle group transferring protons between
the zinc-bound water and surrounding buffer molecules.27
NHE1
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CAII
NHE1
CA
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PO4−
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Figure 4 | CAII interaction with NHE1 is regulated by
phosphorylation. Mitogenic signaling induces activation of kinase
cascades that lead to phosphorylation of NHE1. Phosphorylation of
NHE1 by Mitogen-Activated Protein (MAP) kinases (e.g. ERK, p38,
p90rsk, or NIK) increases NHE1 activity, at least in part, by facilitating
CAII binding to the transporter.
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Most GPI-anchored proteins are targeted to the apical
membrane of polarized epithelial cells.78–81 Nevertheless,
CAIV immunoreactivity detected with a variety of different
CAIV antibodies has also been observed on the basolateral
membranes of proximal tubule segments in human, rabbit,
and rodent species.64,69,82 In distal nephron segments,
however, CAIV expression is detected exclusively on the
luminal or apical membrane.69 In a recent study83 using a
Percoll density-gradient separation of apical from basolateral
membrane vesicles, we characterized the polarity and the
molecular form of CAIV immunoreactivity in rabbit kidney
cortex, and found that CAIV was expressed on both the
apical and basolateral membranes of proximal tubule
epithelia, whereas alkaline phosphatase, which is also
expressed in the kidney as a GPI-anchored protein, was
expressed exclusively on apical membranes. Indeed, the
basolateral membranes enriched from kidney cortex ex-
pressed CAIV immunoreactivity that was identical in
molecular weight to that in apical membrane fractions83
(Figure 5). These results ruled out the possibility that
antibodies to CAIV were cross-reacting with another CA
isoform (e.g. CAXII) expressed in basolateral membranes of
the proximal tubule. The amount of CAIV in basolateral
membrane fractions comprised a substantial portion
(B30%) of the total CAIV protein, suggesting that
basolaterally expressed CAIV could facilitate acid/base
transport in the proximal tubule.
CAIV expressed in basolateral and apical membranes from
kidney cortex were equally sensitive to phosphatidylinositol-
dependent phospholipase C (PI-PLC) cleavage (see Figure 5),
indicating that CAIV is expressed on both membranes as a
GPI-anchored protein.83 Furthermore, we found no evidence
for expression of a B3 kDa larger molecular weight species
corresponding to a putative transmembrane form of CAIV in
kidney cortex. Expression of CAIV as a transmembrane
protein has been reported in normal pancreatic tissues, where
CAIV expressed on the luminal or apical surface of ductal
cells was insensitive to PI-PLC cleavage and was detected by a
polyclonal antisera raised against the COOH terminal tail
that is cleaved upon GPI-anchor attachment.84 The func-
tional significance of transmembrane CAIV is unclear, as
cleavage of the COOH-terminal tail of CAIV has been
reported to be necessary for realization of full enzyme
activity.85 Carboxypeptidase M and PrPC are two other
examples of GPI-anchored proteins that are either targeted to
both apical and basolateral membranes (carboxypeptidase
M)86 or are preferentially sorted to basolateral membranes
(PrPC)87 in MDCK cells. In another cell culture model,
Fischer rat thyroid epithelial cells, six out of nine detectable
endogenous GPI-anchored proteins were localized on the
basolateral surface, two were apical and one was not
polarized.88 However, the CAIV study83 may be the first
report demonstrating both apical and basolateral targeting of
a GPI-anchored protein in polarized epithelial cells from
normal tissue. Thus, CAIV may serve as an excellent model
protein for the study of the determinants that control cellular
trafficking of GPI-anchored proteins in polarized epithelial
cells.
CAIV interacts with members of the BT family of
transporters to form the extracellular component of a
bicarbonate transport metabolon (Figure 6). Evidence for
direct interaction between CAIV and anion exchangers was
first reported by Sterling et al.89 who showed that CAIV
expressed in HEK293 lysates binds to AE1, AE2, and AE3
immobilized on polyvinylidene fluoride membranes, and that
co-transfection of AE1 with CAIV shifts the distribution of
CAIV in sucrose-density gradients. Subsequently, the inter-
action of CAIV with NBC1 was demonstrated by gel overlay
assay.90 The influence of CAIV on bicarbonate transport was
demonstrated in HEK293 cells transiently transfected with
AE’s or NBC1, in which CAII (V143Y) reduced the rate of
bicarbonate transport, and the transport rate was restored
when CAIV was co-transfected with dominant-negative CAII
(V143Y). Acetazolamide inhibited the effect of CAIV co-
transfection on bicarbonate transport rate demonstrating
that CAIV hydratase activity was required.89 Similarly, in
HEK293 cells transfected with NBC1, co-transfection of
CAIV increased cell pH recovery from an acid load and this
effect of CAIV was also inhibited by acetazolamide.90 Casey
and co-workers mapped the CAIV binding region to
extracellular loop 4 (EC4) of AE’s and NBC1. GST fusion
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Figure 5 | CAIV is expressed on the apical and basolateral
membranes of proximal tubule as a GPI-anchored protein.
Membrane vesicles from rabbit kidney cortex were separated
into basolateral and apical membrane-enriched fractions by
centrifugation through a Percoll density gradient. The levels of NHE3
and Naþ , Kþ -ATPase in membrane vesicle fractions determined
by densitometry of Western blotting (upper panel). Linkage of
CAIV via a GPI anchor was determined by sensitivity to cleavage by
PI-PLC. Membrane vesicle fractions were treated with PI-PLC- and
GPI-anchored/transmembrane proteins were separated from
non-GPI-linked protein by Triton X-114 phase extraction. Lower
portion of this panel shows levels of CAIV in the aqueous (AQ) and
detergent phases (DG) of control and PI-PLC-treated fractions
determined by Western blotting with anti-rabbit CAIV (YDQR). Note
that fractions 6 and 8 are basolateral and 12 and 14 are apical.
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proteins containing EC4, but not EC3, from either AE1 or
NBC1 pulled down CAIV from a cell lysate of transfected
HEK293 cells.89 Alignment of the amino-acid sequence
within EC4 of anion exchangers and NBC isoforms reveals
highly conserved motifs that putatively bind CAIV.90 The
function of a conserved RGW sequence within EC4, was
demonstrated by mutating G767T in the NBC1 EC4; this
fusion peptide did not bind CAIV in pull-down assays, and
this mutation abrogated the effect of co-expression of CAIV
on NBC1-mediated cell pH recovery from an acid load.
CAIV associates with NBC1 to form the extracellular
component of a bicarbonate transport metabolon in a non-
polarized epithelial cell model.90 Studies performed in our
laboratory have established that a basolaterally expressed
membrane-associated CA facilitates bicarbonate and fluid
reabsorption in the proximal tubule segments.91 Evidence for
basolateral CAIV expression in kidney cortex suggests that
this isoform contributes, at least in part, to the basolateral CA
activity that facilitates bicarbonate co-transport by NBC1 in
the renal proximal tubule.
CAXIV and CAXV
CAXIV was originally cloned from mouse kidney9 and
subsequently a full-length complementary DNA for the
human sequence was obtained from spinal cord mRNA.10
In both species a B1.7 kb transcript encodes a 337 amino-
acid polypeptide with a predicted molecular mass of
37.5 kDa. CAXIV is most closely related in terms of amino
acid similarity to CAXII. The expressed protein is catalyti-
cally active and the hydratase activity is inhibited by
acetazolamide, but not sulfonamide.10 The expressed human
form appears to be much less active than CAII,10 whereas the
mouse form appears to have activity that is comparable to
CAII92 (see Figure 2). CAXIV is a type I transmembrane
protein; the polypeptide contains a hydrophobic N-terminal
signal sequence and a putative transmembrane domain at the
C-terminus. CAXIV has two cysteine resides that are
predicted to form a disulfide bond and are well conserved
among membrane-associated CA isoforms.
In mice, human, and rabbit species, CAXIV is abundantly
expressed in heart, skeletal muscle, liver, and in mice and
humans abundant expression was also observed in
brain.9,10,63 Abundant expression of CAXIV in the kidney is
observed only in rodent species.9 Immunohistochemical
studies of expression in mouse kidney reveal that CAXIV is
predominantly expressed on the apical membranes of S1 and
S2 segments in the proximal tubule, overlapping with CAIV
in the S2 segment, suggesting that CAXIV plays an important
role in bicarbonate reabsorption in the mouse proximal
tubule. CAXIV is also expressed on the luminal side of the
thick ascending limb, indicating that in rodent species
CAXIV accounts for luminal membrane CA activity in this
segment.92 In contrast to mouse kidney, CAXIV is not
abundantly expressed in human kidney10 and CAXIV mRNA
and protein are virtually undetectable in rabbit kidney
cortex.63
A complementary DNA sequence for a novel CA isoform,
CAXV, was submitted to the NCBI in 2000 (GenBanks
accession no. AF231122), and Hilvo et al.12 recently reported
expression of CAXV mRNA in mouse tissues including
kidney and brain. However, in humans the three candidate
genes for CAXV are pseudogenes. Whereas CAXV is similar
to CAIV in that it is expressed as a GPI-anchored protein, the
enzymatic activity is comparable to CAIII (see Figure 2),
which is several logs lower than CAII and non-rodent
orthologs of CAIV.12 Thus, CAXIV most likely accounts for
much of the apical hydratase activity observed in acidifying
nephron segments within the rodent kidney. The expression
of CAXIV and CAXV in mice, but not in humans and rabbits,
may reflect a compensatory evolutionary response to the
reduced activity of CAIV in rodents owing to the G63-Q
substitution32 (see Figure 2). Compensatory expression of
additional membrane-associated CA isoforms in the prox-
imal tubule emphasizes the importance of membrane-
associated CA hydratase activity in the regulation of acid/
base transport within the kidney. The high activity of CAIV
in humans may have made CAs XIV and XV superfluous in
evolution; therefore CAXIV expression would not be
conserved in the proximal tubule and CAXV would become
a pseudogene in humans.
CAXII and CAIX
CAXII is a type I transmembrane protein of 354 and 355
amino acids in humans and rabbit, respectively, with a
predicted molecular mass B40 kDa. CAXII is a one-pass
transmembrane protein expressing an extracellular CA
domain with a unique short extracellular segment and a
hydrophilic cytoplasmic tail, and one pair of conserved
cysteine residues that putatively form one intramolecular
disulfide bond.13,20,21 Human and rabbit CAXII are 83%
identical and the expressed proteins (43–44 kDa) are
Ion transporter X
Extracellular
Cytosol
HCO3−
HCO3−
CO2 + H2O
CO2 + H2O
CAII
CA (?)
+H+
+H+
Figure 6 | A bicarbonate transport metabolon. A schematic model
illustrating interactions between CAII and membrane-bound CA
isoforms with BTs (e.g. X¼AE1; ?¼CAIV). CAs provide the ‘push’ and
‘pull’ for bicarbonate transport via mass action by supplying or
dissipating substrate.
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catalytically active. Human CAXII was initially reported to
exhibit 16% of activity of CAIV in COS cell transfectants,20
whereas the activity of rabbit CAXII expressed in inner
medullary collecting duct cell transfectants was comparable
to CAIV (with the exception that CAXII hydratase activity
was inhibited by 1–2% SDS).21 Subsequently, using oxygen-
18 exchange, Ulmasov et al.93 showed that a recombinant
secretory form of human CAXII, as well as membrane-bound
CAXII expressed in CHO cells, had catalytic rates of CO2
hydration that were comparable to human CAIV but less
than CAII (see Figure 2). The tissue distribution of CAXII is
perhaps the most limited of the CA isoforms with abundant
expression of CAXII restricted to kidney and colon of
human, mouse, and rabbits,20,21,94 and the endometrial
epithelium and prostate in humans.13,95
Immunohistochemical studies of CAXII expression in
human kidney revealed abundant expression of CAXII in the
basolateral membranes of the thick ascending limb of Henle’s
loop, distal convoluted tubules, and principal cells of the
collecting duct96 (see Figure 3). Weak basolateral staining was
also observed in proximal convoluted tubules. Expression of
CAXII mRNA in the rabbit nephron was observed in the
proximal convoluted and straight tubules, cortical and
medullary collecting ducts, thick ascending limb of Henle,
and papillary epithelium, but not in glomeruli or S3
segments.21 CAXII protein expression in the rabbit kidney
has not yet been determined owing to a lack of a suitable
antibody. In contrast to results in human kidney, but
consistent with expression of CAXII mRNA in rabbits,
immunohistochemical studies in mice revealed strong
basolateral staining of CAXII in S1 and S2 proximal tubule
segments, as well as in Hþ -secreting a-intercalated cells of
the cortical and medullary collecting ducts.97 Despite
apparent discrepancies for observed CAXII expression in
different species, one can conclude that CAXII is expressed
basolaterally in Hþ -secreting cells in the kidney; its relatively
high abundance in rodent kidney cells that transport protons
at high rates may be related to the slow catalytic activity of
CAIV in these species. Although CAXII is expressed on the
basolateral membrane of epithelial cells in the kidney and
colon, the association of CAXII with basolaterally expressed
transporters to form transport metabolons has not as yet
been reported.
CAIX is a 54/58 kDa N-glycosylated single-pass trans-
membrane protein19 that, in addition to a conserved
extracellular catalytic domain, contains an N-terminal
proteoglycan-like domain that functions in cell adhesion
and can be shed by stimulus-dependent activation of
metalloproteinase activity.22,98 CAIX is catalytically active
and exhibits hydratase activity that is comparable to CAIV99
(see Figure 2). In cultured cells CAIX expression is density
dependent,100 and thus, in contrast to other CA isoforms
CAIX may have dual functional roles in intercellular
communication and acid/base physiology.22,101
CAIX is abundantly expressed in the proximal gastro-
intestinal tract including the stomach and gall bladder but
not in normal kidney.63,102,103 CAIX expression is also
observed in the basolateral membrane of enterocytes of
duodenum and jejunum, with most abundant expression
occurring in the crypts in regions where epithelial cells
exhibit high proliferative capacity.102 The function of CAIX
in the gastric mucosa has yet to be defined, but basolateral
expression of CAIX suggests a role in facilitation of chloride/
bicarbonate exchange resulting in bicarbonate extrusion
across the basolateral membrane of gastric parietal cells
coupled with proton secretion by gastric Hþ , KþATPase.104
However, CAIX expression is not restricted to parietal cells,
and whereas CAIX-deficient mice exhibit gastric hyperplasia,
they do not exhibit marked deficits in parietal cell number or
gastric acid secretion.104 Nevertheless, CAIX function in the
proximal gastrointestinal tract is most likely directly or
indirectly coupled to gastric acid secretion. In a recent study
we demonstrated that induction of CAIX during rabbit
maturation coincided with upregulation of the Hþ ,
KþATPase a-subunit,.63 Thus, CAIX likely facilitates Hþ /
HCO3
 transport in order to maintain cell pH in gastric and
duodenal epithelium exposed to gastric acid in addition to
facilitating bicarbonate extrusion in acid-secreting parietal
cells.
CAIX and CAXII function in RCC
CAs IX and XII are tumor-associated antigens whose
expression is induced by hypoxia,105 and expression of these
two isoforms is consistently observed in clear-cell carcinoma
of the kidney. Renal cell carcinoma (RCC) accounts for
roughly 3% of adult malignancy and 90–95% of neoplasms
arising from the kidney.106 RCC often presents with few
symptoms and has a high incidence of metastatic disease
progression at first diagnosis.106,107 Defects in the von
Hippel–Lindau tumor suppressor gene appear to be respon-
sible for approximately 60% of cases of sporadic clear-cell
RCC.107 Ectopic overexpression of CAIX in RCC can result
from inactivation of the von Hippel–Lindau tumor suppres-
sor gene complex by frame-shift mutations,108 leading to
stabilization of hypoxia inducible factor-1a which regulates
trans-activation of CAIX gene expression.109,110 CAs IX and
XII may promote tumor growth and survival via facilitation
of acid/base transport that enables tumor cell growth and
survival in hypoxic, acidic environments105,111and also by
modulating E-cadherin-mediated cell adhesion.101 Consistent
with this hypothesis is the observation that CAIX and CAXII
expression is localized to areas of necrotic tumor foci.105
Robertson et al.112 reported that blockade of hypoxia-
mediated CAIX induction by gene silencing with small-
interfering RNA slowed growth and reduced survival during
hypoxia of breast carcinoma cells, but had no effect on
invasiveness. CAIX may also participate in mitogenic signal
transduction. Dorai et al.113 recently reported that CAIX is
phosphorylated on tyrosine (residue 449 in the cytoplasmic
tail domain) and associates with the regulatory p85 subunit
of phosphatidylinositol 30-kinase in an epidermal growth
factor-dependent manner in RCC cell lines. In this study
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expression of CAIX in RCCs correlated with increased
phosphatidylinositol 30-kinase-dependent Akt phosphoryla-
tion. The phosphorylation of CAIX in the midst of these cell
signaling systems forms the basis of a vicious cycle in the
progression of clear-cell RCC: the CAIX-mediated activation
of Akt promotes the expression of hypoxia inducible factor-
1a, which in turn promotes the expression of CAIX, which
promotes tumor survival under hypoxic conditions.113
It has been proposed that CAIX activity facilitates the
acidification of extracellular milieu surrounding cancer cells
by converting CO2 that has diffused to the extracellular space
back into bicarbonate and protons. This would enable the
Na+-driven bicarbonate-chloride exchanger on the cell
membrane to transport these newly generated HCO3
 ions
back into the cytoplasm113 (Figure 7). This transport process
results in the net export of protons and allows cancer cells to
buffer their cell pH to neutrality and thereby facilitate their
biosynthetic reactions. The resulting extracellular acidic
microenvironment is conducive to activating cell surface
proteases such as cathepsin B and matrix metalloprotease-9,
releasing growth factors, and suppressing the immune
function of effector T cells.113 Consistent with this model is
the observation in transfected MDCK cells that CAIX
expression facilitated extracellular acidification when cells
were exposed to hypoxia.111 This effect required the CA
domain, but not the proteoglycan domain, of CAIX and was
reduced by CAIX-selective inhibitors. Interestingly, in this
same study a fluorescence tagged CAIX inhibitor bound
primarily to CAIX-expressing cells that had been exposed to
hypoxia; hypoxia may also stimulate structural changes
within the active site of the CAIX molecule.111 A role for
CAIX in tumor cell invasion was also suggested by the
observation that acetazolamide, a CA inhibitor, reduces
invasiveness of renal cancer cells in an in vitro model of
metastasis.114 Additional studies are required to identify
associations of CAs IX and XII with acid/base transporters
and their role in acid/base homeostasis in normal tissue
physiology as well as in tumor cell proliferation, metastases,
and survival in hypoxia.
OVERVIEW OF CARBONIC ANHYDRASE FUNCTION IN
REGULATION OF ACID/BASE HOMEOSTASIS IN CELLS
OF THE PROXIMAL AND DISTAL NEPHRON AND RCC
Proximal tubule epithelial cell
Co-expression and association of CAs with transporters
markedly enhances Hþ /HCO3
 transport;90 via mass action
CAs provide the ‘push’ and ‘pull’ for Hþ /HCO3
 transport by
accumulating or dissipating substrate (see Figure 6). In the
renal proximal tubule filtered bicarbonate and protons
secreted by NHE3 activity form carbonic acid (H2CO3) that
is dehydrated by the CA activity of CAIV (and CAXIV in
rodent species) expressed at the brush border of the proximal
tubule, thereby enabling passive diffusion of CO2 into the cell
(Figure 8). Although NHE3 contains a putative CAII binding
motif,59 whether CAII and/or CAIV associate with NHE3 to
facilitate sodium/proton exchange in the apical membrane of
proximal tubule epithelia has not yet been established. CAII
may also associate with SLC26A6 in the apical membrane,
however the contribution of a CAII/SLC26A6 transport
metabolon to Hþ /HCO3
 transport in the renal proximal
tubule is unclear; formate rather than bicarbonate may be the
physiological substrate for SLC26A6 in the proximal tubule.50
Furthermore, the intensity of CAII/SLC26A6 interaction may
be low owing to AT1aR signaling that disrupts CAII binding
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Figure 7 | Model for CA function in acid/base homeostasis in RCC.
CAII facilitates acid secretion by NHE1-mediated sodium/hydrogen
exchange that plays a pivotal role in maintaining cell pH of rapidly
dividing cell populations. CAIX (and perhaps CAXII) may facilitate
extracellular acidification by catalyzing the formation of H2CO3 and
HCO3
 from expired CO2. Juxtaposition of CAIX with an electroneutral
sodium bicarbonate co-transporter or Na+-driven chloride/
bicarbonate exchanger may enhance the conversion of CO2 to
bicarbonate, thereby enabling bicarbonate influx to help buffer cell
pH during anaerobic metabolism under hypoxic conditions. This
would also result in the extracellular accumulation of protons
contributing to acidosis.
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Figure 8 | Model for function of CAs in bicarbonate reabsorption
in the proximal tubule. Filtered bicarbonate and protons secreted
by NHE3 activity form H2CO3 that is dehydrated by CAIV expressed at
the brush border of the proximal tubule, and CO2 passively diffuses
into the cell. CAII associated with kNBC1 on the basolateral
membrane hydrates CO2 to provide substrate for electrogenic
sodium bicarbonate transport by kNBC1 in the 3:1 mode.
Basolaterally expressed CAIV, and perhaps CAXII, associated with
kNBC1 facilitate reabsorption by dissipating bicarbonate at the
basolateral surface.
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to SLC26A6 via a PKC-dependent mechanism.56 At the
basolateral membrane CAII associated with kNBC144 hy-
drates CO2 to provide substrate for electrogenic sodium
bicarbonate transport by kNBC1 in 3:1 mode. Membrane-
associated CAs, which include CAIV and CAXII, with CA
catalytic domains on the extracellular face of the basolateral
membrane may associate with kNBC1 to dissipate bicarbo-
nate or H2CO3 at the basolateral surface and thereby facilitate
bicarbonate reabsorption.90
a-Intercalated cells of the CCD
In the CCD a-intercalated cells contribute to urinary
acidification by the secretion of protons via the activity of
apically expressed vacuolar Hþ -ATPase (Figure 9) and to a
lesser extent HþKþ -ATPase. In addition, a-intercalated cells
reabsorb remnants of filtered bicarbonate that is titrated by
secreted protons and dehydrated by apically expressed CAIV.
Bicarbonate reabsorption is also facilitated by apical NBC3-
mediated electroneutral sodium bicarbonate co-transport,47
which is facilitated CAII on the interior of the membrane.49
At the basolateral surface CAII also facilitates bicarbonate
efflux by AE1-mediated chloride/bicarbonate exchange.39,41,42
CAXII may contribute to bicarbonate reabsorption mediated
by AE1 via dehydration of bicarbonate or H2CO3 at the
basolateral surface of a-intercalated cells. However, associa-
tion between CAXII and AE1 to form the extracellular
component of a bicarbonate transport metabolon has not
been reported (Figure 9).
Renal clear-cell carcinoma
Ectopic expression of CAIX in RCC may enable tumor cells
to survive and proliferate in hypoxic acidic environments by
facilitating Hþ /HCO3
 transport mechanisms that promote
extracellular acidification and maintenance of cell pH (see
Figure 7). Although the identity of acid/base transporters that
associate with CAIX in normal gastric tissue and in
neoplasms has not been determined extensively, it is
interesting to speculate that CAIX catalyzes hydration of
CO2 generated by respiration and thereby facilitates bicarbo-
nate influx via an associated Naþ -dependent chloride-
bicarbonate exchanger.115 In this scenario bicarbonate influx
coupled with proton secretion by the sodium/proton
exchange activity of NHE1 results in extracellular acidifica-
tion and maintenance of cell pH despite acid production by
anaerobic metabolism. It is likely that CAII also facilitates
tumor cell growth and survival by associating with NHE1 to
facilitate sodium/proton exchange.
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